PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026International Journal of Intellectual Property Management0 citations

Growth of goodwill as an intangible asset in the pharmaceutical industry a critical analysis

APAmarendra PattnaikLDLipsa DashKSKavita Sharma

Key Points

  • This analysis aims to evaluate the importance of goodwill as an intangible asset within the pharmaceutical industry.
  • Conducted a critical analysis of existing literature on goodwill in the pharmaceutical sector.
  • Examined case studies illustrating the impact of goodwill on company valuations and strategies.
  • Identified that companies with strong goodwill often have higher market valuations.
  • Demonstrated that goodwill can significantly influence investor perceptions and trust in pharmaceutical brands.

Abstract

Inderscience is a global company, a dynamic leading independent journal publisher disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pattnaik et al. (2026) studied this question.

synapsesocial.com/papers/6a095bba7880e6d24efe1a33https://doi.org/10.1504/ijipm.2026.10078421
Ask AI
Helpful
Bookmark
Share
View Full Paper